Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
J Vasc Interv Radiol ; 32(6): 826-834, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-33713802

RESUMO

PURPOSE: To investigate the association between hepatic ischemic complications and hepatic artery (HA) collateral vessels and portal venous (PV) impairment after HA embolization for postoperative hemorrhage. MATERIALS AND METHODS: From October 2003 to November 2019, 42 patients underwent HA embolization for postoperative hemorrhage. HA collateral vessels were classified according to visualization after embolization (grade 1, none; grade 2, 1-4 segmental HA; and grade 3, ≥4 segmental HA). Transhepatic portal vein stent placements were performed in the same session for 5 patients (11.9%) with poor HA collateral vessels (grade 1 or 2) and compromised PV flow (>70% stenosis). Hepatic ischemic complications were analyzed for relevance to HA collateral vessels and PV compromise. RESULTS: After HA embolization, HA flow was found to be preserved (grade 3) through intra- and/or extrahepatic collateral vessels in 23 patients (54.8%), and hepatic complications did not occur regardless of PV flow status (0%). Of the 19 patients (45.2%) with poor HA collateral vessels (grade 1 or 2), segmental hepatic infarction occurred in 2 of 15 patients (13.3%) with preserved PV flow (10 naïve and 5 stented). The remaining 4 patients with poor HA collateral vessels and untreated compromised PV flow experienced multisegmental hepatic infarction (n = 3) or hepatic failure (n = 1) (100%) (P < .005). CONCLUSIONS: After HA embolization, preserved HA flow (≥4 segmental HA) lowered the risk of hepatic complications regardless of the PV flow. Based on these findings, transhepatic PV stent placement seems to be an effective intervention for the prevention of hepatic complications in cases of poor HA collateral vessels and compromised PV flow.


Assuntos
Circulação Colateral , Embolização Terapêutica , Artéria Hepática/fisiopatologia , Circulação Hepática , Veia Porta/fisiopatologia , Hemorragia Pós-Operatória/terapia , Idoso , Angioplastia com Balão/instrumentação , Embolização Terapêutica/efeitos adversos , Feminino , Artéria Hepática/diagnóstico por imagem , Infarto Hepático/etiologia , Infarto Hepático/fisiopatologia , Humanos , Isquemia/etiologia , Isquemia/fisiopatologia , Masculino , Pessoa de Meia-Idade , Veia Porta/diagnóstico por imagem , Hemorragia Pós-Operatória/diagnóstico por imagem , Hemorragia Pós-Operatória/fisiopatologia , Estudos Retrospectivos , Stents , Resultado do Tratamento
2.
Clin Nucl Med ; 46(1): e8-e10, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33031234

RESUMO

A 68-year-old man with hereditary hypercoagulability was referred to nuclear medicine for elevated aminotransferases after a recent living-donor liver transplant. A hepatic infarction was suspected. A Tc-mebrofenin SPECT/CT was performed and showed decreased radiotracer uptake in a wedge-shaped distribution in the anterior liver suggestive of a hepatic infarction. Subsequently, an enhanced MRI corroborated the diagnosis. Oral anticoagulation therapy was then initiated, and aminotransferases soon normalized.


Assuntos
Infarto Hepático/diagnóstico por imagem , Iminoácidos , Compostos de Organotecnécio , Tomografia Computadorizada com Tomografia Computadorizada de Emissão de Fóton Único , Idoso , Compostos de Anilina , Glicina , Infarto Hepático/tratamento farmacológico , Infarto Hepático/fisiopatologia , Humanos , Transplante de Fígado , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA